Home » Topics » Regulatory

Regulatory
RSS

CPMP recommends approval of irbesartan in diabetic renal disease

March 13, 2002

CPMP recommends approval of Avonex in early-stage MS

March 11, 2002

CPMP recommends expansion of desloratadine indication to indoor and outdoor allergies

March 8, 2002

AstraZeneca submits sNDA for Arimidex in early breast cancer

March 6, 2002

Connetics' sNDA for Olux accepted by FDA

March 5, 2002

FDA approves Remicade for improvement of physical function in RA

March 5, 2002

NDA filed for Zomig Nasal Spray

March 4, 2002

FDA approves new indication for Plavix in acute coronary syndrome

March 1, 2002

CPMP recommends approval of Glivec for GISTs in Europe

Feb. 27, 2002

Cypress initiates phase II program for milnacipran in fibromyalgia syndrome

Feb. 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...